[Can 67Ga citrate predict the efficacy of chemotherapy early in Hodgkin's lymphoma?].
Delgado
M
M
Servicios de Medicina Nuclear. Hospital Clínico Universitario "Lozano Blesa". Zaragoza. mnup@hcu.lblesa.es
Razola
P
P
Abós
M D
MD
Martí
J L
JL
Murillo
L
L
García
F
F
Prats
E
E
Banzo
J
J
D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D002951:Citrates; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D005708:Gallium; D006689:Hodgkin Disease / Q000000981:diagnostic imaging* / Q000188:drug therapy / Q000532:radiotherapy; D006801:Humans; D008727:Methotrexate / Q000008:administration & dosage; D011241:Prednisone / Q000008:administration & dosage; D011344:Procarbazine / Q000008:administration & dosage; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals; D018714:Radiotherapy, Adjuvant; D011882:Radiotherapy, High-Energy; D012074:Remission Induction; D016896:Treatment Outcome; D014750:Vincristine / Q000008:administration & dosage
D002951:Citrates; D019275:Radiopharmaceuticals; D011344:Procarbazine; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D005708:Gallium; C103850:gallium citrate; D011241:Prednisone; D008727:Methotrexate